← Leaderboards
Curtis Layton
Protillion Biosciences, Inc.
$1,958,320
Attributed
$1,958,320
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $855.3K · FY2020–22$1M$750K$500K$250K$0
'20
'21
'22
Funding mix
By agency
NIH$1,958,320 · 2
By mechanism
R44$1,710,520 · 1
R43$247,800 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “In Situ”
- Chris Karlovich · Leidos Biomedical Research, Inc.$38,534,220
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$26,358,801
- Jacob Ruff · Cornell University$22,500,000
- Rachana Agarwal · Leidos Biomedical Research, Inc.$15,241,462
- Elke Arenholz · Cornell University$14,750,000
- Jacob D Estes · Oregon Health & Science University$14,094,407
Research focus
In SituInstrumentationGenerationsInfrastructureData SetAffinityDetectionFluorescenceGenetic TranscriptionImmobilizationBaseAntibodiesBindingBinding ProteinsBiochemicalAmino AcidsDna BiosynthesisDna SequencingBiophysicsCancer ImmunotherapyCellsHigh Throughput AnalysisChip-SeqLead
Grant awards (3)
Quantitative high-throughput methods for antibody fragment optimization and discovery$855,260
R44 · FY2022 · GM · contact PI
Quantitative high-throughput methods for antibody fragment optimization and discovery$855,260
R44 · FY2021 · GM · contact PI
Large-Scale, Quantitative Protein Affinity Assays on a High-Throughput DNA Sequencing Chip$247,800
R43 · FY2020 · GM · contact PI